TNF and neoplasm: The expression levels of the pro-inflammatory anti-tumor marker Tnfa were a little increased by up to two–three-fold in the RLS40Low, RLS40Low/D, and RLS40Med/D subgroups that were not dependent on DNase I treatment (Figure 5C).